Literature DB >> 10380880

STAT activation by the PDGF receptor requires juxtamembrane phosphorylation sites but not Src tyrosine kinase activation.

C Sachsenmaier1, H B Sadowski, J A Cooper.   

Abstract

Activation of the platelet-derived growth factor (PDGF) receptor tyrosine kinase induces tyrosine phosphorylation of Signal Transducer and Activator of Transcription (STAT) proteins. Since the PDGF receptor also activates the Src tyrosine kinase, it is possible that Src mediates tyrosine phosphorylation of STATs in PDGF-treated cells. Consistent with a role for Src in STAT activation, we found that a PDGF receptor juxtamembrane tyrosine residue required for Src activation is necessary and sufficient for activation of STATs 1 and 3. To test the Src requirement further, we made other mutations in the PDGF receptor juxtamembrane region that increased or decreased Src binding. In epithelial and fibroblast cells, PDGF activated STAT1, 3 and 6 in the absence of detectable binding and activation of Src. In addition, PDGF induced c-myc RNA expression and DNA synthesis even though Src was not detectably activated. The activation of MAP kinase and the induction of c-fos gene expression both correlated with STAT but not Src activation by the receptor. We conclude that juxtamembrane tyrosine phosphorylation is necessary for both Src tyrosine kinase and STAT activation by the betaPDGF receptor, but that both processes are regulated independently by this region.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10380880     DOI: 10.1038/sj.onc.1202694

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  15 in total

1.  Protein kinase PKR is required for platelet-derived growth factor signaling of c-fos gene expression via Erks and Stat3.

Authors:  A Deb; M Zamanian-Daryoush; Z Xu; S Kadereit; B R Williams
Journal:  EMBO J       Date:  2001-05-15       Impact factor: 11.598

2.  Activation of JAK-STAT pathway is required for platelet-derived growth factor-induced proliferation of pancreatic stellate cells.

Authors:  Atsushi Masamune; Masahiro Satoh; Kazuhiro Kikuta; Noriaki Suzuki; Tooru Shimosegawa
Journal:  World J Gastroenterol       Date:  2005-06-14       Impact factor: 5.742

3.  Platelet-derived growth factor (PDGF)-induced activation of signal transducer and activator of transcription (Stat) 5 is mediated by PDGF beta-receptor and is not dependent on c-src, fyn, jak1 or jak2 kinases.

Authors:  K Paukku; S Valgeirsdóttir; P Saharinen; M Bergman; C H Heldin; O Silvennoinen
Journal:  Biochem J       Date:  2000-02-01       Impact factor: 3.857

4.  Fatal myeloproliferation, induced in mice by TEL/PDGFbetaR expression, depends on PDGFbetaR tyrosines 579/581.

Authors:  M H Tomasson; D W Sternberg; I R Williams; M Carroll; D Cain; J C Aster; R L Ilaria; R A Van Etten; D G Gilliland
Journal:  J Clin Invest       Date:  2000-02       Impact factor: 14.808

5.  Myeloproliferative disease induced by TEL-PDGFRB displays dynamic range sensitivity to Stat5 gene dosage.

Authors:  Jennifer A Cain; Zhifu Xiang; Julie O'Neal; Friederike Kreisel; AnnaLynn Colson; Hui Luo; Lothar Hennighausen; Michael H Tomasson
Journal:  Blood       Date:  2007-01-11       Impact factor: 22.113

6.  Signal transducer and activator of transcription 3 promotes angiogenesis and drives malignant progression in glioma.

Authors:  Tiffany A Doucette; Ling-Yuan Kong; Yuhui Yang; Sherise D Ferguson; Jinbo Yang; Jun Wei; Wei Qiao; Gregory N Fuller; Krishna P Bhat; Kenneth Aldape; Waldemar Priebe; Oliver Bögler; Amy B Heimberger; Ganesh Rao
Journal:  Neuro Oncol       Date:  2012-06-29       Impact factor: 12.300

7.  FRS2 via fibroblast growth factor receptor 1 is required for platelet-derived growth factor receptor beta-mediated regulation of vascular smooth muscle marker gene expression.

Authors:  Pei-Yu Chen; Michael Simons; Robert Friesel
Journal:  J Biol Chem       Date:  2009-04-01       Impact factor: 5.157

8.  Towards a quantitative understanding of the MITF-PIAS3-STAT3 connection.

Authors:  Josef Thingnes; Timothy J Lavelle; Arne B Gjuvsland; Stig W Omholt; Eivind Hovig
Journal:  BMC Syst Biol       Date:  2012-02-08

9.  The oncogenic FIP1L1-PDGFRα fusion protein displays skewed signaling properties compared to its wild-type PDGFRα counterpart.

Authors:  Serge Haan; Christelle Bahlawane; Jiali Wang; Petr V Nazarov; Arnaud Muller; René Eulenfeld; Claude Haan; Catherine Rolvering; Laurent Vallar; Venkata P Satagopam; Thomas Sauter; Monique Yvonne Wiesinger
Journal:  JAKSTAT       Date:  2015-07-17

10.  12/15-lipoxygenase contributes to platelet-derived growth factor-induced activation of signal transducer and activator of transcription 3.

Authors:  Tina Blazevic; Andrea V Schwaiberger; Cornelia E Schreiner; Daniel Schachner; Anja M Schaible; Christoph S Grojer; Atanas G Atanasov; Oliver Werz; Verena M Dirsch; Elke H Heiss
Journal:  J Biol Chem       Date:  2013-10-28       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.